Lonestar Heart Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lonestar Heart Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10581
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lonestar Heart Inc (Lonestar Heart) is a pharmaceutical company that focuses on the development of novel cardiac restorative therapies for advanced heart failure. The company offers Algisyl cardiac implantable hydrogel and MyoTec system. Its Algisyl product provides a new treatment option for patients whose heart is losing the ability to pump sufficient oxygen-rich blood to the body and act as a patented gel sourced from marine algae that is injected into specific areas of the weakened and stretched muscle of the heart. Lonestar Heart’s MyoTec system is used as percutaneous catheter for myocardial tissue engineering. The company works in collaboration with academic and private contract partners that include research labs, manufacturers and clinical networks. Lonestar Heart is headquartered in Irvine, California, the US.

Lonestar Heart Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lonestar Heart Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lonestar Heart Inc, Medical Devices Deals, 2012 to YTD 2018 9
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
LoneStar Heart Raises USD4.2 Million in Venture Financing 11
Lonestar Heart Raises USD1 Million in Venture Financing 12
Lonestar Heart Raises USD2.4 Million in Series C Venture Financing 13
Lonestar Raises US$2.4 Million In Series C Financing Round 14
Licensing Agreements 15
Lonestar Heart Acquires Rights from University of Texas Southwestern Medical 15
LoneStar Heart Enters Into Licensing Agreement With UT Southwestern Medical Center For Isoxazoles 16
Lonestar Heart Inc – Key Competitors 17
Lonestar Heart Inc – Key Employees 18
Lonestar Heart Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Key Facts 2
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lonestar Heart Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lonestar Heart Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Lonestar Heart Inc, Medical Devices Deals, 2012 to YTD 2018 9
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
LoneStar Heart Raises USD4.2 Million in Venture Financing 11
Lonestar Heart Raises USD1 Million in Venture Financing 12
Lonestar Heart Raises USD2.4 Million in Series C Venture Financing 13
Lonestar Raises US$2.4 Million In Series C Financing Round 14
Lonestar Heart Acquires Rights from University of Texas Southwestern Medical 15
LoneStar Heart Enters Into Licensing Agreement With UT Southwestern Medical Center For Isoxazoles 16
Lonestar Heart Inc, Key Competitors 17
Lonestar Heart Inc, Key Employees 18
Lonestar Heart Inc, Subsidiaries 19

List of Figures
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lonestar Heart Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lonestar Heart Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Lonestar Heart Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lockheed Martin Corporation:企業のM&A・事業提携・投資動向
    Lockheed Martin Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lockheed Martin Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Bio Blast Pharma Ltd (ORPN):企業の財務・戦略的SWOT分析
    Summary Bio Blast Pharma Ltd (Bioblast Pharma) is a clinical stage biotechnology company that discovers, delivers, and develops clinical therapies for patients with rare and ultra-rare genetic diseases. The company discovers and develops pipeline products using platforms such as cabaletta, a mutant …
  • Teva Pharmaceutical Industries Ltd (TEVA)-製薬・医療分野:企業M&A・提携分析
    Summary Teva Pharmaceutical Industries Ltd (Teva) carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines in central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company off …
  • ARxIUM:医療機器:M&Aディール及び事業提携情報
    Summary ARxIUM, formerly Intelligent Hospital Systems Inc, a subsidiary of Van Humbeck Family, is a medical device company that designs and manufactures automated solutions for the hospital pharmacy. The company’s products include RxWorks pro, workflow, inventory management, IV compounding system, h …
  • WESCO International Inc (WCC):企業の財務・戦略的SWOT分析
    WESCO International Inc (WCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Cubic Corp (CUB):企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Japan Petroleum Exploration Co Ltd (1662):石油・ガス:M&Aディール及び事業提携情報
    Summary Japan Petroleum Exploration Co Ltd (JAPEX) is an oil and gas company that offers exploration, development, production, and sales of oil, natural gas, and other energy resources. The company’s services include acquisition of blocks, development, exploration, supplying, selling, and transporta …
  • NSK Ltd.:企業の戦略・SWOT・財務情報
    NSK Ltd. - Strategy, SWOT and Corporate Finance Report Summary NSK Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Caisse de depot et placement du Quebec:企業の戦略・SWOT・財務分析
    Caisse de depot et placement du Quebec - Strategy, SWOT and Corporate Finance Report Summary Caisse de depot et placement du Quebec - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Sophia Genetics SA:医療機器:M&Aディール及び事業提携情報
    Summary Sophia Genetics SA (Sophia Genetics) is a health tech company that provides technological solutions such as SOPHiA Artificial Intelligence for clinical genomics and next generation sequencing (NGS) data analysis. The company also provides dry lab, bundle solution, and integrated diagnostic s …
  • Newfield Exploration Company:企業の戦略・SWOT・財務情報
    Newfield Exploration Company - Strategy, SWOT and Corporate Finance Report Summary Newfield Exploration Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Doppler SA:企業の戦略・SWOT・財務情報
    Doppler SA - Strategy, SWOT and Corporate Finance Report Summary Doppler SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Woodside Petroleum Ltd (WPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Woodside Petroleum Ltd (Woodside) is an independent oil and gas company that explores, develops, produces and supplies energy. It explores and produces oil and gas from a portfolio of facilities in association with some of the world’s major oil and gas companies. The company operates liquefi …
  • Cancer Genetics Inc (CGIX)-医療機器分野:企業M&A・提携分析
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that offers diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic inform …
  • National Grid Plc:企業の発電所・SWOT分析2018
    National Grid Plc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Moody’s Corporation:企業の戦略・SWOT・財務情報
    Moody's Corporation - Strategy, SWOT and Corporate Finance Report Summary Moody's Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Welltec AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Welltec AS (Welltec) is an oil and gas service provider that develops and offers well technologies and solutions for the oil and gas industries. The company's solutions include wireline services, milling solutions, robotic well solutions, conveyance solutions, clean-out solutions, and mechan …
  • TAG Oil Ltd (TAO):石油・ガス:M&Aディール及び事業提携情報
    Summary TAG Oil Ltd (TAG Oil) is an oil and gas company that explores, develops and produces natural gas and crude oil across Canada. The company owns and operates oil and gas properties in Taranaki Basin and East Coast Basin. It undertakes oil and gas projects such as Boar Hill Frontier, Waitangi H …
  • Facebook, Inc.:戦略・SWOT・企業財務分析
    Facebook, Inc. - Strategy, SWOT and Corporate Finance Report Summary Facebook, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆